However, other studies suggest that despite elevated IGFBP-1 levels, anti-fibrotic treatment does not cause a significant impact on IGFBP-1 expression in idiopathic pulmonary fibrosis (IPF) [108]. The gene discussed is IGFBP1; the disease is pulmonary fibrosis.